Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1833 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed663    
    Printed29    
    Emailed0    
    PDF Downloaded97    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 2000  |  Volume : 42  |  Issue : 3  |  Page : 308-311

Effects of Zopicloone and Lorazepam on ECT Seizure Duration : Clinical Implications of Findings from an Animal Model


1 Additional Professor & Head, Department of Psychopharmacology, NIMHANS, Bangalore-560 029, India
2 Project Officer, Department of Psychopharmacology, NIMHANS, Bangalore-560 029, India
3 Research Associate, Department of Pharmacology, St. John's Medical College, Bangalore-560 034, India
4 Central Animal Research Facility, National Institute of Mental Health and Neurosciences, Bangalore-560 029, India

Correspondence Address:
Chittaranjan Andrade
Additional Professor & Head, Department of Psychopharmacology, NIMHANS, Bangalore-560 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21407962

Rights and PermissionsRights and Permissions

Lorazepam is commonly prescribed to treat insomnia in depressed patients who receive electroconvulsive therapy (ECT); however, lorazepam may interfere with ECT seizure parameters, and may thereby compromise the efficacy of the treatment. This study therefore sought to assess whether zopicione, a hypnotic agent, interferes less with the ECT seizure. For ethical reasons, the study utilized an animal model. Sprague-Dawley rats (n=10/group) received either zopicione (1.5 mg/ kg), lorazepam (0.2 mg/kg), or a placebo equivalent. After 30 minutes, an electroconvulsive shock was administered to the rats. It was observed that the motor seizure duration but not the total motoric phase was significantly attenuated by zopicione. Lorazepam did not impact significantly upon either seizure measure. It is concluded that zopicione may be a suitable hypnotic for patients receiving ECT only if sufficient time is allowed for the drug to be substantially washed out of the body.



[PDF]*

        

Print this article         Email this article